A new demography and aging population, chronic diseases, increased competition, as well as budget constraints demand innovative therapies, pharmaceuticals, medical devices and services. It is crucial for managers in pharmaceutical and medical organizations to gain an in-depth understanding and knowledge of value creation.
The "MBA - Specialization Biotech, Pharma & MedTech Management" builds on a solid theoretical framework complemented by case studies, excursions and discussions with peers. Graduates of the program will be part of a network of successful innovators and entrepreneurs in the field and will be prepared to take over demanding managerial positions in biopharmaceutical and medical device companies in a competitive international environment.
The four specialization modules can also be booked as Certificate Program "Biotech, Pharma & MedTech Management". The modules completed can be credited in terms of content and financially for "MBA - Specialization Biotech, Pharma & MedTech Management".
ACCREDITED: The program is internationally accredited by ACBSP. Danube Business School is member of the PRME initiative of the United Nations.
Executives and entrepreneurs in biotechnology, medical technology, pharmaceutical companies as well as health care organizations, with education in the field of natural sciences, especially medicine, pharmacy, medical technology as well as economics, legal studies or IT.
Studying in Krems